Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Dr. Alexander Eggermont
Based on 168 articles published since 2008
||||
Expertise Level
The expertise of Dr. Alexander Eggermont ranks in the
  • Top 0.011%
  • ... of 99,743 published authors worldwide on Melanoma
  • ... from 2008 through 2018
  • ... based on contributions to 168 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Eggermont, A   ·   Eggermont, A M M   ·   Eggermont, Alexander M   ·   Eggermont, A M   ·   Eggermont, Alexander M M   ·   Eggermont, Alexander   ·   Eggermont, Alexander Mm
Work Locations
Details
Most likely:    Institut Gustave Roussy      
2018
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France · · European Organization for the Research and Treatment of Cancer Headquarters, Brussels, Belgium · Pubmed 30089063
2017
  • Birmingham Clinical Trials Unit, College of Medical and Dental Sciences, Public Health Building, University of Birmingham, Birmingham, B15 2TT, UK. · EORTC Headquarters, Avenue Emmanuel Mounier 83/11, 1200 Brussels, Belgium. · Gustave Roussy Cancer Campus Grand Paris, 114 Rue Edouard Vaillant, 94800, Villejuif, France. · University of Pittsburgh Cancer Institute and School of Medicine, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA. · The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester, M20 4BX, UK. · Mayo Clinic Rochester, 200 First St. SW, Rochester, MN, 55905, USA. · University of Tubingen, Liebermeisterstraße 25, 72076, Tübingen, Germany. · Cancer Research UK Clinical Trials Unit, College of Medical and Dental Sciences, Robert Aitken Institute, University of Birmingham, Birmingham, B15 2TT, UK. Electronic address: · Pubmed 28692949
  • EORTC Headquarters, Brussels, Belgium. Electronic address: · EORTC Headquarters, Brussels, Belgium. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hôpital de la Timone, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Oncology Specialists S C, Park Ridge, IL, USA. · Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Paris. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 28162999
  • Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX. · Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor, The University of Sydney, Sydney, New South Wales, Australia. · Senior Staff Pathologist, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL. · Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia. · Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Co-Director, Melanoma Program; Head, Surgical Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA. · Professor of Medicine, Dermatology, and Translational Science, The University of Pittsburgh School of Medicine, Pittsburgh, PA. · Executive Director, Victorian Comprehensive Cancer Center, Melbourne, Victoria, Australia. · Manager, Clinical Data Management Systems, The University of Texas MD Anderson Cancer Center, Houston, TX. · Director General, Gustave Roussy Cancer Institute, Villejuif, France. · Director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, Boston, MA. · Professor of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 29028110
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; Universite Paris-Sud, Kremlin-Bicêtre, France. Electronic address: · University Hospital Zürich, Department of Dermatology, Zürich, Switzerland. · Pubmed 28968566
  • Laboratory of Immunomonitoring in Oncology, CNRS-UMS 3655 and INSERM-US23, Gustave Roussy Cancer Campus, Villejuif. · Faculty of Pharmacy, Chatenay-Malabry. · Micalis Institute, INRA, AgroParisTech, Paris. · Faculty of Medicine, University Paris-Saclay, Le Kremlin Bicêtre. · Department of Gastroenterology, Kremlin Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin Bicêtre. · Dermatology Unit, Department of Medicine, Gustave Roussy, Cancer Campus, Villejuif. · INSERM U1015, Gustave Roussy, Cancer Campus, Villejuif. · Biostatistics and Epidemiology Unit, Gustave Roussy Cancer Campus (GRCC), Villejuif. · University Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France. · Pubmed 28368458
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075EA Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075EA Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075EA Rotterdam, The Netherlands. Electronic address: · Department of Dermatology, Charité-University of Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: · Department of Internal Medicine, Hematology and Medical Oncology, Armed Forces Hospital, Oberer Eselsberg 40, 89081 Ulm, Germany. Electronic address: · Department of Dermatology, Charité-University of Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: · Board of Directors, Cancer Institute Gustave Roussy, 114 rue Édouard-Vaillant, 94805 Villejuif/Paris-Sud, France. Electronic address: · Department of Dermatology, Charité-University of Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany. · Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Pubmed 28262276
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Melanoma Unit, St George's Foundation University Hospital, London, UK. · Department of Dermatology and Allergology, Cancer Institute Gustave Roussy, Villejuif, France. · Division of Dermato-Oncological Surgery, European Institute of Oncology, Milan, Italy. · Department of Surgical Oncology, Groningen University, University Medical Centre Groningen, Groningen, The Netherlands. · Department of Dermatology and Allergology, Charité - University of Medicine Berlin, Berlin, Germany. · Board of Directors, Cancer Institute Gustave Roussy, Villejuif, France. · Pubmed 28218385
  • Department of Twin Research and Genetic Epidemiology, King's College London, London, UK. · Department of Medical Sciences, University of Turin, Turin, Italy. · Dermatology and Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy. · Dermatology Department, University of Bologna, Bologna, Italy. · Clinical Epidemiology Unit, IDI-IRCSS-FLMM Rome, Rome, Italy. · Surgical Oncology, Veneto Institute of Oncology - IRCCS, Padova, Italy. · Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain. · Institut de Cancérologie, Institut Gustave Roussy, Villejuif, France. · European Institute of Oncology, Milan, Italy. · Mount Vernon Cancer Center, Northwood, UK. · Dermatology Department, Federico II University of Naples, Naples, Italy. · Melanoma Unit, Dermatology Department Hospital Clinic and University of Barcelona, CIBER de Enfermedades Raras, Barcelona, Spain. · Dermatology Department, West Herts NHS Trust, Herts, UK. · Pubmed 27231086
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France · European Organization for Research and Treatment of Cancer, Brussels, Belgium · European Institute of Oncology, Milan, Italy · Pubmed 28121506
2016
  • European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Biostatistics and Methodology Department, Angers University Hospital, Angers, France. Electronic address: · European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Oncology and Pathology Department, Karolinska Institutet, Stockholm, Sweden. · Pubmed 27838512
  • Dermatology Service, Department of Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · University of Pittsburgh, 4200 Fifth Avenue, Pittsburgh, Pennsylvania 15260, USA. · AP-HP, Internal Medicine Department, University Hospital of Bicêtre, 78 Rue du General Leclerc, 94270 Le Kremlin-Bicetre, France. · Paris Sud University, 63 Rue Gabriel Peri, 94270 Le Kremlin Bicêtre, France. · INSERM Unit U1184, 63 Rue Gabriel Peri, 94270 Le Kremlin Bicêtre, France. · Thoracic and Vascular Surgery Service, Centre Chirurgical Marie Lannelongue, 133 Avenue de la Resistance, 92350 Le Plessis-Robinson, France. · AP-HP, Department of Gastroenterology, University Hospital of Bicêtre, Paris Sud University, 78 Rue du General Leclerc, 94270 Le Kremlin-Bicetre, France. · Department of Nephrology, Pitié-Salpêtrière Hospital, 47-83 Boulevard de l'hopital, 75013 Paris, France. · Drug Development Department (DITEP), Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · INSERM Unit U981, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · Biostatistic and Epidemiology Unit, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 27141885
  • Department of Drug Development (DITEP), Gustave Roussy Inserm U981, Univ. Paris-Sud, Université Paris-Saclay, Villejuif. · Department of Internal Medicine and Clinical Immunology, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, Le Kremlin Bicêtre Université Paris Sud 11, Le Kremlin-Bicêtre CEA, DSV/iMETI, Division of Immuno-Virology, IDMIT, Fontenay-aux-Roses INSERM, U1184, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre. · Department of Ophthalmology, Hôpital Universitaire Bicêtre, Le Kremlin Bicêtre. · Department of Rheumatology, Hôpitaux Universitaires Paris-Sud, Hôpital Bicêtre, AP-HP, Le Kremlin Bicêtre. · Department of Nuclear Medicine and Endocrine Tumors, Gustave Roussy, Univ. Paris-Sud, Université Paris-Saclay, Villejuif. · Gastroenterology Unit, Université Paris-Sud, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Sud, Le Kremlin Bicêtre. · Division of Adult Neurology, Hôpital Universitaire Bicêtre, Le Kremlin Bicêtre. · Faculty of Medicine, Université Paris-Saclay, Univ Paris-Sud, Paris-Sud, UMR-S1185, Le Kremlin Bicêtre Unit of Endocrinology and reproductive Health, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Hôpital de Bicêtre, Le Kremlin Bicêtre Unit of Gastroenterology, Institut National de la Santé et de la Recherche Médicale U1185 (P.C.), Le Kremlin Bicêtre. · Department of Nephrology and Transplantation, Bicêtre Hospital, Paris Saclay University, INSERM 1197, Le Kremlin Bicêtre. · Department of Cardiology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Pierre et Marie Curie University [UPMC], Paris-Sorbonne, Paris. · Department of Thoracic and cardiovascular, and transplantation cardio-pulmonary, Hôpital Marie-Lannelongue, Le Plessis-Robinson Univ. Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre. · Hematology Unit, Department of Medical Oncology, Gustave Roussy, Univ. Paris-Sud, Université Paris-Saclay, Villejuif. · Department of Thoracic and cardiovascular, and transplantation cardio-pulmonary, Hôpital Marie-Lannelongue, Le Plessis-Robinson Univ. Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre UMR_S 999, Univ. Paris-Sud; INSERM; Hôpital Marie Lannelongue, Le Plessis Robinson. · Centre Hépato-Biliaire, AP-HP, Hôpital Universitaire Paul Brousse Inserm U1193. · Dermatology Unit, Department of Medical Oncology, Gustave Roussy, Univ. Paris-Sud, Université Paris-Saclay, Villejuif. · Department of Drug Development (DITEP), Gustave Roussy. · Inserm U981, Univ. Paris-Sud, Université Paris-Saclay, Villejuif Dermatology Unit, Department of Medical Oncology, Gustave Roussy, Univ. Paris-Sud, Université Paris-Saclay, Villejuif. · Gustave Roussy Cancer Campus, Villejuif. · Department of Drug Development (DITEP), Gustave Roussy Gustave Roussy Cancer Campus, Villejuif Inserm 1015, Univ. Paris-Sud, Université Paris-Saclay, Villejuif, France · Pubmed 26715621
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; Universite Paris-Sud, Kremlin-Bicêtre, France. Electronic address: · Pubmed 27816830
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. Electronic address: · Department of Dermatology, Venerology and Allergology, Charité - University, Medicine Berlin, Berlin, Germany. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. Electronic address: · Department of Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; General Director, Department of Surgical Oncology, Gustave Roussy Cancer Campus Grand Paris, Villejuif/Paris-Sud, France. Electronic address: · Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: · Pubmed 27669503
  • Department of Dermatology, Institut Roi Albert II, Cliniques Universitaires St Luc, Université catholique de Louvain, Brussels, Belgium. Electronic address: · Institute of Statistics, Biostatistics and Actuarial Sciences, Université catholique de Louvain, Louvain-la-Neuve, Belgium. · Department of Public Health and Surveillance, Scientific Institute of Public Health (WIV-ISP), Brussels, Belgium. · Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · European Organization for Research and Treatment of Cancer, Brussels, Belgium. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Dermatology, Institut Roi Albert II, Cliniques Universitaires St Luc, Université catholique de Louvain, Brussels, Belgium. · Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires St Luc, Université catholique de Louvain, Brussels, Belgium. · Department of Dermatology, Centre Hospitalier Lyon Sud, Lyon 1 University, Lyons Cancer Research Center, France. · Centre for Health Economics Research & Modelling Infectious Diseases, Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, Belgium. · Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels, Belgium. · Pubmed 27592070
  • Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · Pubmed 27522248
  • 1. Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus MC, Rotterdam, The Netherlands. · 2. Departments of Nuclear Medicine and Radiology, Erasmus MC, Rotterdam, the Netherlands. · 3. Gustave Roussy Cancer Campus Grand Paris, Villejuif Paris, France. · 4. Eindhoven University of Technology, Department of Biomedical NMR, Eindhoven, The Netherlands.; 5. Philips Research Eindhoven, Department of Oncology Solutions, Eindhoven, The Netherlands. · Pubmed 27446503
  • Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. Electronic address: · Institute of Dermatology, Catholic University, Rome, Italy. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. · University Department of Dermatology, Université de Versailles-Saint Quentin en Yvelines, APHP, Boulogne, France. · NIHR Biomedical Research Centre, University of Oxford, UK. · Department of Oncology, Odense University Hospital, Denmark. · University Department of Dermatology, Marseille, France. · Melanoma Unit, Department of Dermatology, Hospital Clinic, IDIBAPS, Barcelona, Spain. · Section of Biostatistics and Epidemiology, Leeds Institute of Cancer and Pathology, University of Leeds, UK. · 1(st) Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece. · University Department of Dermatology, Vienna, Austria. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Pubmed 27367293
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Electronic address: · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, ul. W.K. Roentgena 5, 02-781 Warsaw, Poland. Electronic address: · Melanoma Unit, St. George's Foundation University Hospital, Blakshaw Road, Tooting, London SW17 0QT, United Kingdom. Electronic address: · Department of Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Electronic address: · Department of Dermatology, Charité, University of Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany. · Division of Dermato Oncological Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Department of Dermatology, Cancer Institute Gustave Roussy, 114 rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: · Department of Surgical Oncology, Groningen University, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Electronic address: · Cancer Institute Gustave Roussy, 114 rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: · Department of Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Pubmed 27266406
  • INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; Center of Clinical Investigation, Hôpital Necker Enfants Malades, Paris, France. · Saint Antoine Hospital, INSERM ERL 1157-CNRS UMR 7203, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France. · Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA. · Cancer Immunology Branch, Division of Cancer Biology, National Cancer Center, Ilsan, Goyang, Gyeonggi, Korea; Section of Clinical Immunology, Allergy, and Rheumatology, Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA. · Department of Medical Oncology, University Hospital of Besancon, Besancon, France; Clinical Investigational Centre, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM U1098, University of Franche-Comté, Besançon, France. · Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Université de Franche Comté, Service de Dermatologie, Centre Hospitalier Universitaire (CHU), Besançon, France. · Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, France. · Division of Oncology, Department of Medicine, Stanford University, Stanford, California, USA. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France; INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France; Department of Surgery, Gustave Roussy Cancer Center, Villejuif, France; Department of Dermatology, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. Electronic address: · Pubmed 26829031
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · EORTC Headquarters, Brussels, Belgium. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Erasmus MC Cancer Institute - Location Daniel den Hoed, Rotterdam, The Netherlands. · Academisch Medisch Centrum - Universiteit van Amsterdam, Amsterdam, The Netherlands. · Universitaetsspital Zurich, Zürich, Switzerland. · Institut Jules Bordet, Brussels, Belgium. · Charité, Berlin, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · Pubmed 26790144
  • Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands; Erasmus Optical Imaging Center, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: · Pubmed 26707830
  • Department of Dermatology, Institut Roi Albert II, Cliniques Universitaires St Luc, Université catholique de Louvain, Brussels, Belgium. Electronic address: · Institute of Statistics, Biostatistics and Actuarial Sciences, Université catholique de Louvain, Louvain-la-Neuve, Belgium. · Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium; Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels, Belgium. · Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · European Organization for Research and Treatment of Cancer, Brussels, Belgium. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Belgian Cancer Registry, Brussels, Belgium. · Department of Public Health, Erasmus Medical Center, Erasmus University Rotterdam, The Netherlands. · Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires St Luc, Université catholique de Louvain, Brussels, Belgium. · Department of Dermatology, Lyon 1 University, Centre Hospitalier Lyon Sud, France. · Centre for Health Economics Research & Modelling Infectious Diseases, Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, Belgium. · Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels, Belgium. · Pubmed 26693897
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, POBox 1738, 3000, DR, Rotterdam, The Netherlands. · Institut Gustave Roussy, Villejuif, France. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, POBox 1738, 3000, DR, Rotterdam, The Netherlands. · Pubmed 26518763
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
2015
  • University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · University Hospital Essen, Essen, Germany. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sheba Medical Center, Tel Hashomer, Israel. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. · University Medical Center, Mainz, Germany. · Universitätsklinikum Tübingen, Tübingen, Germany. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. · St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. · University of North Carolina, Chapel Hill, NC, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Merck & Co, Kenilworth, NJ, USA. · University of California, San Francisco, San Francisco, CA, USA. · Pubmed 26115796
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Aix-Marseille University, Hôpital de La Timone APHM, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Oncology Specialists SC, Park Ridge, IL, USA. · Assistance Publique Hôpitaux de Paris, Dermatology and CIC Departments, Hôpital Saint Louis, University Paris 7, INSERM U976, France. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, Alberta, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 25840693
  • Gustave Roussy Cancer Campus Grand Paris, 114 rue Edouard Vaillant, 94805 Villejuif, France; INSERM U1015, 94805 Villejuif, France. · Gustave Roussy Cancer Campus Grand Paris, 114 rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 26613660
  • Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. · Institut National de la Recherche Agronomique (INRA), Micalis-UMR1319, 78360 Jouy-en-Josas, France. · University of Lille, CNRS, INSERM, Centre Hospitalier Régional Universitaire de Lille, Institut Pasteur de Lille, U1019, UMR 8204, Centre d'Infection et d'Immunité de Lille (CIIL), F-59000 Lille, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Department of Radiation Oncology, New York University, New York, NY, USA. · Microenvironment and Immunity Unit, Institut Pasteur, Paris, France. · Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. · Department of Genetics and Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. · Animalerie Centrale, Institut Pasteur, Paris, France. · Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale (IPBS), Toulouse, France. Université de Toulouse, Université Paul Sabatier, IPBS, F-31077 Toulouse, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Service de microbiologie, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Laboratory of Immunomonitoring in Oncology, UMS 3655 CNRS/US 23 INSERM, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. INSERM U981, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. INSERM U848, Villejuif, France. Equipe 11 Labellisée-Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, INSERM U1138, Paris, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France. · Unité des Rickettsies, Faculté de Médecine, Université de la Méditerranée, Marseille, France. · Institut Pasteur, Unit of Biology and Genetics of the Bacterial Cell Wall, Paris, France. INSERM, Equipe Avenir, Paris, France. · University of Paris Sud XI, Kremlin-Bicêtre, France. Gastroenterology Department, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Paris, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Pubmed 26541610
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology Department of Surgery, Erasmus MC Cancer Center, Rotterdam, The Netherlands. · Laboratory of Experimental Surgical Oncology, Department of Surgical Oncology, Erasmus MC Cancer Institute, PO Box 2040, 3000, CA, Rotterdam, The Netherlands. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology Department of Surgery, Erasmus MC Cancer Center, Rotterdam, The Netherlands. · Department of Pharmaceutics, Mashhad University of Medical Sciences, Mashhad, Iran. · Institut Gustave Roussy, Villejuif, France. · Pubmed 26202516
  • 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] INSERM, Unité Mixte de Recherche_S959, I, Paris, France [2] Assistance-Publique Hopitaux de Paris, Hôpital Pitié-Salpêtrière, Biotherapy, Paris, France. · INSERM U753, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] Department of Medical Oncology, IGR, Villejuif, France. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Ludwig Center for Cancer Immunotherapy, Department of Immunology, and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland [2] Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland. · Department of Dermatology, University Hospital Essen, Germany. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Bristol-Myers Squibb, Redwood City, CA, USA. · Earle A Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · 1] QIMR Berghofer Medical Research Institute, Herston, 4006, Queensland, Australia [2] School of Medicine, The University of Queensland, Herston, QLD 4006, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Department of Medical Oncology, IGR, Villejuif, France [4] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France [4] Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, INSERM U 1138, Paris, France [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France [6] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France [4] Department of Medical Oncology, IGR, Villejuif, France. · Pubmed 25582080
  • Dept. of Dermatology, Harzklinikum Quedlinburg, Germany. · Department of Surgical Oncology, Erasmus University Medical Center - Daniel den Hoed Cancer Center, Rotterdam, Netherlands. · Surgery, Institut de Cancérologie, Gustav Roussy, Villejuif, France. · Department of Dermatology, Charité, Humboldt University, Berlin, Germany. · Pubmed 24764213
2014
  • Melanoma Unit and INSERM U981, Gustave Roussy Cancer Institute, Grand Paris, Villejuif, France; Erasmus University Medical Centre, Rotterdam, Netherlands. Electronic address: · Department of Pathology, McGill University & Lady Davis Institute for Medical Research, Montreal, QC, Canada. · Melanoma Unit and INSERM U981, Gustave Roussy Cancer Institute, Grand Paris, Villejuif, France. · Pubmed 24054424
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Cancer Institute, Gustave Roussy Cancer Campus, Grand Paris, 114 rue Édouard Vaillant, 94805 Villejuif, France. · Pubmed 25311352
  • 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France [4]. · 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3]. · 1] Inserm UMR981, Villejuif F-94805, France [2]. · Inserm UMR981, Villejuif F-94805, France. · 1] Inserm UMR981, Villejuif F-94805, France [2] Department of Surgical and Perioperative Sciences, Umeå University, Umeå SE-90187, Sweden (O.H.); CNRS UMR3348, Institut Curie, Orsay F-91405, France (S.V.). · Gustave Roussy, Pathology Department, Villejuif F-94805, France. · Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France. · CNRS-Strasbourg University, UMR7200, Illkirch F-67400, France. · 1] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [2] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France. · 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France. · 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France [4] Department of Surgical and Perioperative Sciences, Umeå University, Umeå SE-90187, Sweden (O.H.); CNRS UMR3348, Institut Curie, Orsay F-91405, France (S.V.). · Pubmed 25079330
  • Department of Dermatology, Charité, Humboldt University of Berlin, Berlin, Germany; European Organization for Research and Treatment of Cancer (EORTC) Melanoma Group (MG), Brussels, Belgium. Electronic address: · Department of Surgical Oncology, Erasmus University Medical Center - Daniel den Hoed Cancer Center, Rotterdam, The Netherlands; European Organization for Research and Treatment of Cancer (EORTC) Melanoma Group (MG), Brussels, Belgium. · Department of Dermatology, Charité, Humboldt University of Berlin, Berlin, Germany. · Department of Hematology and Oncology, Armed Forces Hospital, Ulm, Germany. · Institut de Cancérologie Gustav Roussy, Paris-Sud/Villejuif, France; European Organization for Research and Treatment of Cancer (EORTC) Melanoma Group (MG), Brussels, Belgium. · Pubmed 24999208
  • Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Cancer Institute, Gustave Roussy Cancer Campus, Grand Paris, 114 rue Édouard Vaillant, 94805 Villejuif, France. · Pubmed 24710577
  • 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA. [2]. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA. · Department of Dermatology, Maurizio Bufalini Hospital, Cesena, Italy. · Department of Dermatology, University of L'Aquila, L'Aquila, Italy. · 1] Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. [2] Genetics of Rare Hereditary Cancers, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Service de Génétique, Gustave Roussy, Villejuif, France. · 1] Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain. [2] Department of Dermatology, Universidad Católica de Valencia, Valencia, Spain. · Université Paris Descartes, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France. · 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA. [2] Cancer Genomics Research Laboratory, NCI-Frederick, SAIC-Frederick, Inc., Frederick, Maryland, USA. · Genetics of Rare Hereditary Cancers, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Dermatology, Hospital General Universitario de Alicante, Alicante, Spain. · Laboratory of Molecular Biology, Instituto Valenciano de Oncología, Valencia, Spain. · 1] INSERM, UMR 946, Genetic Variation and Human Diseases Unit, Paris, France. [2] Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France. · 1] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. · SAS Quantome, Paris, France. · Laboratory of Molecular Gerontology, National Institute on Aging, US National Institutes of Health, US Department of Health and Human Services, Baltimore, Maryland, USA. · Section of Medical Sciences, School of Molecular Biosciences, Washington State University, Spokane, Washington, USA. · Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. · SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Simulation, Analysis and Mathematical Modeling Group, Advanced Biomedical Computing Center, Frederick, Maryland, USA. · 1] Service de Génétique, Gustave Roussy, Villejuif, France. [2] Université Paris-Sud, Kremlin Bicêtre France, Gustave Roussy, Villejuif, France. · 1] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [3] Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain (CEPH), Paris, France. · Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. · Pubmed 24686846
  • 1] Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands [2]. · 1] Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands [2] Department of Biochemistry, The Rosalind and Morris Goodman Cancer Centre, McGill University, Montreal, Quebec H3G 1Y6, Canada [3]. · Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Division of Medical Oncology, Cancer Systems Biology Centre and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Division of Pathology, Cancer Systems Biology Centre and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · 1] Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands [2] Department of Pathology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · 1] University of Torino, Department of Oncology, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy [2] Candiolo Cancer Institute - FPO, IRCCS, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy. · Candiolo Cancer Institute - FPO, IRCCS, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy. · 1] University of Torino, Department of Oncology, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy [2] Candiolo Cancer Institute - FPO, IRCCS, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy [3] FIRC Institute of Molecular Oncology (IFOM), 20139 Milano, Italy. · Pubmed 24670642
  • The University of Queensland, UQ Centre for Clinical Research, Experimental Dermatology Group, Brisbane, QLD, Australia; The University of Queensland, UQ Diamantina Institute, Translational Research Institute, Woolloongabba, QLD, Australia. Electronic address: · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · QIMR Berghofer Medical Research Institute, Cancer and Population Studies Group, Brisbane, Australia. · The University of Queensland, UQ Centre for Clinical Research, Experimental Dermatology Group, Brisbane, QLD, Australia. · Queensland Melanoma Project, Discipline of Surgery, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, QLD, Australia. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Institut de Cancérologie Gustave Roussy, Villejuif-Paris, France. · QIMR Berghofer Medical Research Institute, Cancer and Population Studies Group, Brisbane, Australia; Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK. · Pubmed 24613127
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands; Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands; Institut de Cancérologie Gustave Roussy, 94800 Paris, France. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands. Electronic address: · Pubmed 24269966
  • Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Institut de Cancerologie Gustav Roussy, Villejuif, Paris-Sud, France. Electronic address: · Pubmed 24074765
  • Cancer Institute, Gustave Roussy Cancer Campus, Grand Paris, 114 rue Édouard Vaillant, 94805 Villejuif, France. · Department of Dermatology, Gustave Roussy Cancer Campus, Grand Paris, 114 rue Édouard Vaillant, 94805 Villejuif, France. · Pubmed 24590131
2013
2012
  • Cancer Institute Gustave-Roussy, Villejuif/Paris-Sud 94800, France. · Pubmed 22918930
  • Institut de Cancérologie Gustave Roussy, Villejuif, Paris, France. · Pubmed 22234255
  • Institut de Cancérologie Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, Paris-Sud, France. · Pubmed 22231762
  • Institute de Cancérologie Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, Paris-Sud, France. · Pubmed 23008300
  • Institut de Cancérologie Gustave Roussy, Villejuif, France. · Pubmed 22056637
2011
  • Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, France. · Pubmed 21802280
2010
2018
  • European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; The Christie NHS Foundation Trust, Manchester, UK; University of Pittsburgh Cancer Institute and School of Medicine, Pittsburgh, PA; Mayo Clinic Rochester, Rochester, MN; University of Tubingen, Tubingen, Germany; University of Edinburgh, Western General Hospital, Edinburgh, UK; Bristol-Myers Squibb, Wallingford, CT; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK; Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK; Universitas Brawijaya, Malang, Indonesia; IDDI, Louvain-la-Neuve, Belgium. · Pubmed 28922786
  • From the Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay, Villejuif (A.M.M.E., C.R.), Hospices Civils de Lyon Cancer Institute, Cancer Research Center of Lyon, Lyon University, Lyon (S.D.), and Aix-Marseille University, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille (J.-J.G.) - all in France; Netherlands Cancer Institute-Antoni van Leeuwenhoek (C.U.B., A.C.J.A.) and VU University Medical Center (A.J.M.E.), Amsterdam, and Radboud University Medical Center Nijmegen, Nijmegen (R.K.) - all in the Netherlands; Azienda Ospedaliera Papa Giovanni XXIII, Bergamo (M. Mandala), Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples (P.A.A.), and Universita Degli Studi Di Siena-Policlinico le Scotte, Siena (M. Maio) - all in Italy; Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals (G.V.L.) and Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney (M.S.C.), Sydney, Princess Alexandra Hospital, University of Queensland, Brisbane (V.A.), Alfred Hospital (A.H.) and Peter MacCallum Cancer Centre (S. Sandhu), Melbourne, VIC, and Fiona Stanley Hospital-University of Western Australia-Edith Cowan University Perth, Perth (A.K.) - all in Australia; Cancer Research Center, Moscow (M.L.); Royal Marsden Hospital, London (J.L.); Hospital Clinic Universitari de Barcelona, Barcelona (S.P.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); University Hospital Essen, Essen and German Cancer Consortium, Heidelberg (D.S.), and the Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover (R.G.) - all in Germany; Washington University School of Medicine, St. Louis (L.H.-A.); Centre Hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du CHUM, Montreal (R.J.); Christie NHS Foundation Trust, Manchester, United Kingdom (P.L.); Merck, Kenilworth, NJ (N.I.); and the European Organization for the Research and Treatment of Cancer Headquarters, Brussels (S.M., S. Suciu). · Pubmed 29658430
2016
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France; the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy; University of Zurich Hospital, Zurich, Switzerland (R.D.); Memorial Sloan Kettering Cancer Center, New York (J.D.W.); Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark; the Angeles Clinic and Research Institute, Los Angeles (O.H.); Oncology Specialists, Park Ridge, IL (J.M.R.); Cross Cancer Institute, Edmonton, AB, Canada (M.S.); H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.); Broomfield Hospital, Chelmsford, United Kingdom (S.T.); Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany; Dana-Farber Cancer Institute, Boston (F.S.H.); Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.); and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
  • aDepartment of Oncology, Odense University Hospital, Odense C bThe Finsen Laboratory, Rigshospitalet, and Biotech Research and Innovation Centre, University of Copenhagen, København Departments of cOncology dMedicine ePathology, Herlev University Hospital, Herlev fAarhus University Hospital, Aarhus, Denmark gDepartment of Surgical Oncology, Erasmus University Medical Center-Daniel Den Hoed Cancer Center, Rotterdam, The Netherlands hKarolinska Institute, Stockholm, Sweden iEORTC Headquarters, Brussels, Belgium jGustave Roussy Cancer Institute, Villejuif, France. · Pubmed 27076041
  • aDepartment of Dermatology, Venerology and Allergology, Charité - University of Medicine Berlin, Berlin bDepartment of Dermatology, Harz Skin Cancer Center, Quedlinburg, Germany cDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam dDepartment of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands eGustav Roussy, Institute of Oncology, Villejuif/Paris-Sud, France. · Pubmed 26881876
2015
  • 1Service of Oncology, Hospital La Paz, Madrid, Spain; 2Department of Dermatology, Hopital Ste Marguerite, Marseille, France; 3Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 4Department of Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; 5Department of Dermatology (CR), and General Director (AE), Institute Gustave Roussy, Villejuif Cedex, France; 6First Department of Medicine, University of Athens Medical School, Athens, Greece; 7Department of Oncology, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia; 8Service of Oncology, Clinica Universitaria de Navarra, Pamplona, Spain; 9Department of Dermatology, University of Kiel, Kiel, Germany; and 10Department of Dermatology, University Hospital Essen, Essen, Germany. · Pubmed 24413374
  • 1Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori-Fondazione G. Pascale, Naples, Italy; 2Odense University Hospital, Odense, Denmark; 3Newcastle University, Newcastle, Australia; 4Instituto de Oncologia Angel Rolfo, Buenos Aires, Argentina; 5Institut Gustave Roussy, Villejuif, France; 6University of Kiel, Kiel, Germany; 7Hospital La Paz, Madrid, Spain; and 8Institut Gustave Roussy, Villejuif, France. · Pubmed 24185314
  • 1First Department of Medicine, Athens University Medical School, Athens, Greece; 2Division of Medical Oncology, Baskent University School of Medicine, Adana, Turkey; 3Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy; 4Department of Biotherapy, Blokhin Cancer Center, Moscow, Russia; 5Department of Dermatology, Medical University of Vienna, Vienna, Austria; 6Department of Dermatology, Institute Gustave Roussy, Villejuif Cedex, France; 7Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel; 8Department of Dermatologie, University of Kiel, Kiel, Germany; and 9Oncology Service, Hospital La Paz, Madrid, Spain. · Pubmed 24176884
  • aDepartment of Surgical Oncology, Erasmus MC-Cancer Institute, Rotterdam, The Netherlands bGustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Pubmed 26110555
2014
  • Authors' Affiliations: Cancer Institute Gustave Roussy; Departments of Epidemiology and Statistics and Dermatology; Stabilité génétique et oncogenèse UMR 8200; Clinical Oncology, Melanoma Branch, Cancer Institute Gustave Roussy; Department of BioPathology, Translational Research Laboratory and Biobank, Institute Gustave Roussy; Institut National de la Santé et de la Recherche Medicale (INSERM), U1015; Center of Clinical Investigations CBT507, Biotherapy, Villejuif; INSERM U1102, Institut de Cancérologie de l'Ouest, Saint Herblain; INSERM, U892, Institut de Recherche Thérapeutique, Nantes; INSERM, U1016, Saint Vincent de Paul Hospital; INSERM U1016, CNRS UMR8104, Cochin Institute; Faculté Paris Sud-Université Paris XI, Paris, France; and IRCCS San Matteo University Hospital Foundation, Pavia, Italy. · Pubmed 24197135
  • aDepartment of Dermatology, Charité, Humboldt University of Berlin, Berlin bDepartment of Dermatology, University of Mainz, Mainz, Germany cDepartment of Surgical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands dInstitute Gustave Roussy Cancer Center, Villejuif, Paris Sud, France. · Pubmed 25003535
2013
  • Alexander M.M. Eggermont, Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, and Université Paris-Sud, Kremlin Bicêtre, Paris, France; Stefan Suciu, Larissa Polders, and Michel Praet, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Jeremy Marsden, University Hospital Birmingham, Birmingham; Philippa Corrie, Addenbrookes Hospital, Cambridge; Poulam M. Patel, University of Nottingham, Nottingham; Neville Davidson, Broomfield Hospital, Broomfield, United Kingdom; Mario Santinami, Istituto Nazionale dei Tumori, Milan; Paolo A. Ascierto, Istituto Nazionale Tumori Fondazione Pascale, Napoli; Lorenzo Borgognoni, Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence; Maria Grazia Bernengo, University Hospital Turin, Turin, Italy; Steinar Aamdal, Oslo University Hospital and Radium Hospital, Oslo, Norway; Wim H. Kruit, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands; Lars Bastholt, Odense University Hospital, Odense, Denmark; and Alan Spatz, McGill University and Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Pubmed 24019551
  • Gustave Roussy Comprehensive Cancer Center, 114 Rue Edouard Vaillant, 94800 Villejuif/Paris-Sud, France. · Pubmed 23907003
  • Dermatology Unit, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Pubmed 23439861
2012
  • Department of Surgery, Institut Gustave-Roussy, Villejuif Cedex, France. · Pubmed 22241290
Probable:    Miscellaneous cities in France      
2018
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France · · European Organization for the Research and Treatment of Cancer Headquarters, Brussels, Belgium · Pubmed 30089063
2011
  • Department of Epidemiology and Biostatistics, International Prevention Research Institute, France. · Pubmed 21192263
Probable:    Universite Paris 11 Sud      
2017
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; Universite Paris-Sud, Kremlin-Bicêtre, France. Electronic address: · University Hospital Zürich, Department of Dermatology, Zürich, Switzerland. · Pubmed 28968566
2016
  • Dermatology Service, Department of Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · University of Pittsburgh, 4200 Fifth Avenue, Pittsburgh, Pennsylvania 15260, USA. · AP-HP, Internal Medicine Department, University Hospital of Bicêtre, 78 Rue du General Leclerc, 94270 Le Kremlin-Bicetre, France. · Paris Sud University, 63 Rue Gabriel Peri, 94270 Le Kremlin Bicêtre, France. · INSERM Unit U1184, 63 Rue Gabriel Peri, 94270 Le Kremlin Bicêtre, France. · Thoracic and Vascular Surgery Service, Centre Chirurgical Marie Lannelongue, 133 Avenue de la Resistance, 92350 Le Plessis-Robinson, France. · AP-HP, Department of Gastroenterology, University Hospital of Bicêtre, Paris Sud University, 78 Rue du General Leclerc, 94270 Le Kremlin-Bicetre, France. · Department of Nephrology, Pitié-Salpêtrière Hospital, 47-83 Boulevard de l'hopital, 75013 Paris, France. · Drug Development Department (DITEP), Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · INSERM Unit U981, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · Biostatistic and Epidemiology Unit, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 27141885
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; Universite Paris-Sud, Kremlin-Bicêtre, France. Electronic address: · Pubmed 27816830
2015
  • Gustave Roussy Cancer Campus Grand Paris and University Paris-Sud, Paris, France. Electronic address: · Medical Oncology and Immunotherapy, University Hospital Siena, Italy. · Gustave Roussy Cancer Campus Grand Paris and University Paris-Sud, Paris, France. · Pubmed 25965361
  • University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · University Hospital Essen, Essen, Germany. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sheba Medical Center, Tel Hashomer, Israel. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. · University Medical Center, Mainz, Germany. · Universitätsklinikum Tübingen, Tübingen, Germany. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. · St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. · University of North Carolina, Chapel Hill, NC, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Merck & Co, Kenilworth, NJ, USA. · University of California, San Francisco, San Francisco, CA, USA. · Pubmed 26115796
2014
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France [4]. · 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3]. · 1] Inserm UMR981, Villejuif F-94805, France [2]. · Inserm UMR981, Villejuif F-94805, France. · 1] Inserm UMR981, Villejuif F-94805, France [2] Department of Surgical and Perioperative Sciences, Umeå University, Umeå SE-90187, Sweden (O.H.); CNRS UMR3348, Institut Curie, Orsay F-91405, France (S.V.). · Gustave Roussy, Pathology Department, Villejuif F-94805, France. · Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France. · CNRS-Strasbourg University, UMR7200, Illkirch F-67400, France. · 1] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [2] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France. · 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France. · 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France [4] Department of Surgical and Perioperative Sciences, Umeå University, Umeå SE-90187, Sweden (O.H.); CNRS UMR3348, Institut Curie, Orsay F-91405, France (S.V.). · Pubmed 25079330
  • 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA. [2]. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA. · Department of Dermatology, Maurizio Bufalini Hospital, Cesena, Italy. · Department of Dermatology, University of L'Aquila, L'Aquila, Italy. · 1] Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. [2] Genetics of Rare Hereditary Cancers, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Service de Génétique, Gustave Roussy, Villejuif, France. · 1] Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain. [2] Department of Dermatology, Universidad Católica de Valencia, Valencia, Spain. · Université Paris Descartes, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France. · 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA. [2] Cancer Genomics Research Laboratory, NCI-Frederick, SAIC-Frederick, Inc., Frederick, Maryland, USA. · Genetics of Rare Hereditary Cancers, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Dermatology, Hospital General Universitario de Alicante, Alicante, Spain. · Laboratory of Molecular Biology, Instituto Valenciano de Oncología, Valencia, Spain. · 1] INSERM, UMR 946, Genetic Variation and Human Diseases Unit, Paris, France. [2] Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France. · 1] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. · SAS Quantome, Paris, France. · Laboratory of Molecular Gerontology, National Institute on Aging, US National Institutes of Health, US Department of Health and Human Services, Baltimore, Maryland, USA. · Section of Medical Sciences, School of Molecular Biosciences, Washington State University, Spokane, Washington, USA. · Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. · SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Simulation, Analysis and Mathematical Modeling Group, Advanced Biomedical Computing Center, Frederick, Maryland, USA. · 1] Service de Génétique, Gustave Roussy, Villejuif, France. [2] Université Paris-Sud, Kremlin Bicêtre France, Gustave Roussy, Villejuif, France. · 1] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [3] Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain (CEPH), Paris, France. · Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. · Pubmed 24686846
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
2016
  • aDepartment of Dermatology, Venerology and Allergology, Charité - University of Medicine Berlin, Berlin bDepartment of Dermatology, Harz Skin Cancer Center, Quedlinburg, Germany cDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam dDepartment of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands eGustav Roussy, Institute of Oncology, Villejuif/Paris-Sud, France. · Pubmed 26881876
2014
  • Authors' Affiliations: Cancer Institute Gustave Roussy; Departments of Epidemiology and Statistics and Dermatology; Stabilité génétique et oncogenèse UMR 8200; Clinical Oncology, Melanoma Branch, Cancer Institute Gustave Roussy; Department of BioPathology, Translational Research Laboratory and Biobank, Institute Gustave Roussy; Institut National de la Santé et de la Recherche Medicale (INSERM), U1015; Center of Clinical Investigations CBT507, Biotherapy, Villejuif; INSERM U1102, Institut de Cancérologie de l'Ouest, Saint Herblain; INSERM, U892, Institut de Recherche Thérapeutique, Nantes; INSERM, U1016, Saint Vincent de Paul Hospital; INSERM U1016, CNRS UMR8104, Cochin Institute; Faculté Paris Sud-Université Paris XI, Paris, France; and IRCCS San Matteo University Hospital Foundation, Pavia, Italy. · Pubmed 24197135
  • aDepartment of Dermatology, Charité, Humboldt University of Berlin, Berlin bDepartment of Dermatology, University of Mainz, Mainz, Germany cDepartment of Surgical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands dInstitute Gustave Roussy Cancer Center, Villejuif, Paris Sud, France. · Pubmed 25003535
2013
  • Alexander M.M. Eggermont, Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, and Université Paris-Sud, Kremlin Bicêtre, Paris, France; Stefan Suciu, Larissa Polders, and Michel Praet, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Jeremy Marsden, University Hospital Birmingham, Birmingham; Philippa Corrie, Addenbrookes Hospital, Cambridge; Poulam M. Patel, University of Nottingham, Nottingham; Neville Davidson, Broomfield Hospital, Broomfield, United Kingdom; Mario Santinami, Istituto Nazionale dei Tumori, Milan; Paolo A. Ascierto, Istituto Nazionale Tumori Fondazione Pascale, Napoli; Lorenzo Borgognoni, Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence; Maria Grazia Bernengo, University Hospital Turin, Turin, Italy; Steinar Aamdal, Oslo University Hospital and Radium Hospital, Oslo, Norway; Wim H. Kruit, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands; Lars Bastholt, Odense University Hospital, Odense, Denmark; and Alan Spatz, McGill University and Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Pubmed 24019551
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 168 total) written by Dr. Alexander Eggermont about Melanoma:

  • Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant Therapy. 2018
  • Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma. 2018
  • Adjuvant Pembrolizumab in Resected Stage III Melanoma. 2018
  • Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis. 2017
  • Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial. 2017
  • Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. 2017
  • The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients. 2017
  • Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. 2017
  • Long-term results of ultrasound guided fine needle aspiration cytology in conjunction with sentinel node biopsy support step-wise approach in melanoma. 2017
  • Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma. 2017
Show List of Full Article Records
Google Searches

Learn more about Dr. Alexander Eggermont using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Institut Gustave Roussy
Miscellaneous cities in France
Universite Paris 11 Sud
Affiliation Timeline What is this?
Institut Gustave Roussy
2018
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France · · European Organization for the Research and Treatment of Cancer Headquarters, Brussels, Belgium · Pubmed 30089063
2017
  • Birmingham Clinical Trials Unit, College of Medical and Dental Sciences, Public Health Building, University of Birmingham, Birmingham, B15 2TT, UK. · EORTC Headquarters, Avenue Emmanuel Mounier 83/11, 1200 Brussels, Belgium. · Gustave Roussy Cancer Campus Grand Paris, 114 Rue Edouard Vaillant, 94800, Villejuif, France. · University of Pittsburgh Cancer Institute and School of Medicine, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA. · The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester, M20 4BX, UK. · Mayo Clinic Rochester, 200 First St. SW, Rochester, MN, 55905, USA. · University of Tubingen, Liebermeisterstraße 25, 72076, Tübingen, Germany. · Cancer Research UK Clinical Trials Unit, College of Medical and Dental Sciences, Robert Aitken Institute, University of Birmingham, Birmingham, B15 2TT, UK. Electronic address: · Pubmed 28692949
  • EORTC Headquarters, Brussels, Belgium. Electronic address: · EORTC Headquarters, Brussels, Belgium. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hôpital de la Timone, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Oncology Specialists S C, Park Ridge, IL, USA. · Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Paris. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 28162999
  • Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX. · Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor, The University of Sydney, Sydney, New South Wales, Australia. · Senior Staff Pathologist, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL. · Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia. · Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Co-Director, Melanoma Program; Head, Surgical Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA. · Professor of Medicine, Dermatology, and Translational Science, The University of Pittsburgh School of Medicine, Pittsburgh, PA. · Executive Director, Victorian Comprehensive Cancer Center, Melbourne, Victoria, Australia. · Manager, Clinical Data Management Systems, The University of Texas MD Anderson Cancer Center, Houston, TX. · Director General, Gustave Roussy Cancer Institute, Villejuif, France. · Director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, Boston, MA. · Professor of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 29028110
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; Universite Paris-Sud, Kremlin-Bicêtre, France. Electronic address: · University Hospital Zürich, Department of Dermatology, Zürich, Switzerland. · Pubmed 28968566
  • Laboratory of Immunomonitoring in Oncology, CNRS-UMS 3655 and INSERM-US23, Gustave Roussy Cancer Campus, Villejuif. · Faculty of Pharmacy, Chatenay-Malabry. · Micalis Institute, INRA, AgroParisTech, Paris. · Faculty of Medicine, University Paris-Saclay, Le Kremlin Bicêtre. · Department of Gastroenterology, Kremlin Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin Bicêtre. · Dermatology Unit, Department of Medicine, Gustave Roussy, Cancer Campus, Villejuif. · INSERM U1015, Gustave Roussy, Cancer Campus, Villejuif. · Biostatistics and Epidemiology Unit, Gustave Roussy Cancer Campus (GRCC), Villejuif. · University Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France. · Pubmed 28368458
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075EA Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075EA Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075EA Rotterdam, The Netherlands. Electronic address: · Department of Dermatology, Charité-University of Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: · Department of Internal Medicine, Hematology and Medical Oncology, Armed Forces Hospital, Oberer Eselsberg 40, 89081 Ulm, Germany. Electronic address: · Department of Dermatology, Charité-University of Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: · Board of Directors, Cancer Institute Gustave Roussy, 114 rue Édouard-Vaillant, 94805 Villejuif/Paris-Sud, France. Electronic address: · Department of Dermatology, Charité-University of Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany. · Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Pubmed 28262276
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Melanoma Unit, St George's Foundation University Hospital, London, UK. · Department of Dermatology and Allergology, Cancer Institute Gustave Roussy, Villejuif, France. · Division of Dermato-Oncological Surgery, European Institute of Oncology, Milan, Italy. · Department of Surgical Oncology, Groningen University, University Medical Centre Groningen, Groningen, The Netherlands. · Department of Dermatology and Allergology, Charité - University of Medicine Berlin, Berlin, Germany. · Board of Directors, Cancer Institute Gustave Roussy, Villejuif, France. · Pubmed 28218385
  • Department of Twin Research and Genetic Epidemiology, King's College London, London, UK. · Department of Medical Sciences, University of Turin, Turin, Italy. · Dermatology and Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy. · Dermatology Department, University of Bologna, Bologna, Italy. · Clinical Epidemiology Unit, IDI-IRCSS-FLMM Rome, Rome, Italy. · Surgical Oncology, Veneto Institute of Oncology - IRCCS, Padova, Italy. · Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain. · Institut de Cancérologie, Institut Gustave Roussy, Villejuif, France. · European Institute of Oncology, Milan, Italy. · Mount Vernon Cancer Center, Northwood, UK. · Dermatology Department, Federico II University of Naples, Naples, Italy. · Melanoma Unit, Dermatology Department Hospital Clinic and University of Barcelona, CIBER de Enfermedades Raras, Barcelona, Spain. · Dermatology Department, West Herts NHS Trust, Herts, UK. · Pubmed 27231086
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France · European Organization for Research and Treatment of Cancer, Brussels, Belgium · European Institute of Oncology, Milan, Italy · Pubmed 28121506
2016
  • European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Biostatistics and Methodology Department, Angers University Hospital, Angers, France. Electronic address: · European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Oncology and Pathology Department, Karolinska Institutet, Stockholm, Sweden. · Pubmed 27838512
  • Dermatology Service, Department of Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · University of Pittsburgh, 4200 Fifth Avenue, Pittsburgh, Pennsylvania 15260, USA. · AP-HP, Internal Medicine Department, University Hospital of Bicêtre, 78 Rue du General Leclerc, 94270 Le Kremlin-Bicetre, France. · Paris Sud University, 63 Rue Gabriel Peri, 94270 Le Kremlin Bicêtre, France. · INSERM Unit U1184, 63 Rue Gabriel Peri, 94270 Le Kremlin Bicêtre, France. · Thoracic and Vascular Surgery Service, Centre Chirurgical Marie Lannelongue, 133 Avenue de la Resistance, 92350 Le Plessis-Robinson, France. · AP-HP, Department of Gastroenterology, University Hospital of Bicêtre, Paris Sud University, 78 Rue du General Leclerc, 94270 Le Kremlin-Bicetre, France. · Department of Nephrology, Pitié-Salpêtrière Hospital, 47-83 Boulevard de l'hopital, 75013 Paris, France. · Drug Development Department (DITEP), Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · INSERM Unit U981, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · Biostatistic and Epidemiology Unit, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 27141885
  • Department of Drug Development (DITEP), Gustave Roussy Inserm U981, Univ. Paris-Sud, Université Paris-Saclay, Villejuif. · Department of Internal Medicine and Clinical Immunology, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, Le Kremlin Bicêtre Université Paris Sud 11, Le Kremlin-Bicêtre CEA, DSV/iMETI, Division of Immuno-Virology, IDMIT, Fontenay-aux-Roses INSERM, U1184, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre. · Department of Ophthalmology, Hôpital Universitaire Bicêtre, Le Kremlin Bicêtre. · Department of Rheumatology, Hôpitaux Universitaires Paris-Sud, Hôpital Bicêtre, AP-HP, Le Kremlin Bicêtre. · Department of Nuclear Medicine and Endocrine Tumors, Gustave Roussy, Univ. Paris-Sud, Université Paris-Saclay, Villejuif. · Gastroenterology Unit, Université Paris-Sud, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Sud, Le Kremlin Bicêtre. · Division of Adult Neurology, Hôpital Universitaire Bicêtre, Le Kremlin Bicêtre. · Faculty of Medicine, Université Paris-Saclay, Univ Paris-Sud, Paris-Sud, UMR-S1185, Le Kremlin Bicêtre Unit of Endocrinology and reproductive Health, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Hôpital de Bicêtre, Le Kremlin Bicêtre Unit of Gastroenterology, Institut National de la Santé et de la Recherche Médicale U1185 (P.C.), Le Kremlin Bicêtre. · Department of Nephrology and Transplantation, Bicêtre Hospital, Paris Saclay University, INSERM 1197, Le Kremlin Bicêtre. · Department of Cardiology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Pierre et Marie Curie University [UPMC], Paris-Sorbonne, Paris. · Department of Thoracic and cardiovascular, and transplantation cardio-pulmonary, Hôpital Marie-Lannelongue, Le Plessis-Robinson Univ. Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre. · Hematology Unit, Department of Medical Oncology, Gustave Roussy, Univ. Paris-Sud, Université Paris-Saclay, Villejuif. · Department of Thoracic and cardiovascular, and transplantation cardio-pulmonary, Hôpital Marie-Lannelongue, Le Plessis-Robinson Univ. Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre UMR_S 999, Univ. Paris-Sud; INSERM; Hôpital Marie Lannelongue, Le Plessis Robinson. · Centre Hépato-Biliaire, AP-HP, Hôpital Universitaire Paul Brousse Inserm U1193. · Dermatology Unit, Department of Medical Oncology, Gustave Roussy, Univ. Paris-Sud, Université Paris-Saclay, Villejuif. · Department of Drug Development (DITEP), Gustave Roussy. · Inserm U981, Univ. Paris-Sud, Université Paris-Saclay, Villejuif Dermatology Unit, Department of Medical Oncology, Gustave Roussy, Univ. Paris-Sud, Université Paris-Saclay, Villejuif. · Gustave Roussy Cancer Campus, Villejuif. · Department of Drug Development (DITEP), Gustave Roussy Gustave Roussy Cancer Campus, Villejuif Inserm 1015, Univ. Paris-Sud, Université Paris-Saclay, Villejuif, France · Pubmed 26715621
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; Universite Paris-Sud, Kremlin-Bicêtre, France. Electronic address: · Pubmed 27816830
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. Electronic address: · Department of Dermatology, Venerology and Allergology, Charité - University, Medicine Berlin, Berlin, Germany. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. Electronic address: · Department of Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; General Director, Department of Surgical Oncology, Gustave Roussy Cancer Campus Grand Paris, Villejuif/Paris-Sud, France. Electronic address: · Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: · Pubmed 27669503
  • Department of Dermatology, Institut Roi Albert II, Cliniques Universitaires St Luc, Université catholique de Louvain, Brussels, Belgium. Electronic address: · Institute of Statistics, Biostatistics and Actuarial Sciences, Université catholique de Louvain, Louvain-la-Neuve, Belgium. · Department of Public Health and Surveillance, Scientific Institute of Public Health (WIV-ISP), Brussels, Belgium. · Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · European Organization for Research and Treatment of Cancer, Brussels, Belgium. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Dermatology, Institut Roi Albert II, Cliniques Universitaires St Luc, Université catholique de Louvain, Brussels, Belgium. · Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires St Luc, Université catholique de Louvain, Brussels, Belgium. · Department of Dermatology, Centre Hospitalier Lyon Sud, Lyon 1 University, Lyons Cancer Research Center, France. · Centre for Health Economics Research & Modelling Infectious Diseases, Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, Belgium. · Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels, Belgium. · Pubmed 27592070
  • Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · Pubmed 27522248
  • 1. Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus MC, Rotterdam, The Netherlands. · 2. Departments of Nuclear Medicine and Radiology, Erasmus MC, Rotterdam, the Netherlands. · 3. Gustave Roussy Cancer Campus Grand Paris, Villejuif Paris, France. · 4. Eindhoven University of Technology, Department of Biomedical NMR, Eindhoven, The Netherlands.; 5. Philips Research Eindhoven, Department of Oncology Solutions, Eindhoven, The Netherlands. · Pubmed 27446503
  • Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. Electronic address: · Institute of Dermatology, Catholic University, Rome, Italy. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. · University Department of Dermatology, Université de Versailles-Saint Quentin en Yvelines, APHP, Boulogne, France. · NIHR Biomedical Research Centre, University of Oxford, UK. · Department of Oncology, Odense University Hospital, Denmark. · University Department of Dermatology, Marseille, France. · Melanoma Unit, Department of Dermatology, Hospital Clinic, IDIBAPS, Barcelona, Spain. · Section of Biostatistics and Epidemiology, Leeds Institute of Cancer and Pathology, University of Leeds, UK. · 1(st) Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece. · University Department of Dermatology, Vienna, Austria. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Pubmed 27367293
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Electronic address: · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, ul. W.K. Roentgena 5, 02-781 Warsaw, Poland. Electronic address: · Melanoma Unit, St. George's Foundation University Hospital, Blakshaw Road, Tooting, London SW17 0QT, United Kingdom. Electronic address: · Department of Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Electronic address: · Department of Dermatology, Charité, University of Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany. · Division of Dermato Oncological Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Department of Dermatology, Cancer Institute Gustave Roussy, 114 rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: · Department of Surgical Oncology, Groningen University, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Electronic address: · Cancer Institute Gustave Roussy, 114 rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: · Department of Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Pubmed 27266406
  • INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; Center of Clinical Investigation, Hôpital Necker Enfants Malades, Paris, France. · Saint Antoine Hospital, INSERM ERL 1157-CNRS UMR 7203, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France. · Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA. · Cancer Immunology Branch, Division of Cancer Biology, National Cancer Center, Ilsan, Goyang, Gyeonggi, Korea; Section of Clinical Immunology, Allergy, and Rheumatology, Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA. · Department of Medical Oncology, University Hospital of Besancon, Besancon, France; Clinical Investigational Centre, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM U1098, University of Franche-Comté, Besançon, France. · Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Université de Franche Comté, Service de Dermatologie, Centre Hospitalier Universitaire (CHU), Besançon, France. · Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, France. · Division of Oncology, Department of Medicine, Stanford University, Stanford, California, USA. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France; INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France; Department of Surgery, Gustave Roussy Cancer Center, Villejuif, France; Department of Dermatology, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. Electronic address: · Pubmed 26829031
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · EORTC Headquarters, Brussels, Belgium. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Erasmus MC Cancer Institute - Location Daniel den Hoed, Rotterdam, The Netherlands. · Academisch Medisch Centrum - Universiteit van Amsterdam, Amsterdam, The Netherlands. · Universitaetsspital Zurich, Zürich, Switzerland. · Institut Jules Bordet, Brussels, Belgium. · Charité, Berlin, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · Pubmed 26790144
  • Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands; Erasmus Optical Imaging Center, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: · Pubmed 26707830
  • Department of Dermatology, Institut Roi Albert II, Cliniques Universitaires St Luc, Université catholique de Louvain, Brussels, Belgium. Electronic address: · Institute of Statistics, Biostatistics and Actuarial Sciences, Université catholique de Louvain, Louvain-la-Neuve, Belgium. · Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium; Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels, Belgium. · Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · European Organization for Research and Treatment of Cancer, Brussels, Belgium. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Belgian Cancer Registry, Brussels, Belgium. · Department of Public Health, Erasmus Medical Center, Erasmus University Rotterdam, The Netherlands. · Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires St Luc, Université catholique de Louvain, Brussels, Belgium. · Department of Dermatology, Lyon 1 University, Centre Hospitalier Lyon Sud, France. · Centre for Health Economics Research & Modelling Infectious Diseases, Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, Belgium. · Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels, Belgium. · Pubmed 26693897
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, POBox 1738, 3000, DR, Rotterdam, The Netherlands. · Institut Gustave Roussy, Villejuif, France. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, POBox 1738, 3000, DR, Rotterdam, The Netherlands. · Pubmed 26518763
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
2015
  • University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · University Hospital Essen, Essen, Germany. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sheba Medical Center, Tel Hashomer, Israel. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. · University Medical Center, Mainz, Germany. · Universitätsklinikum Tübingen, Tübingen, Germany. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. · St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. · University of North Carolina, Chapel Hill, NC, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Merck & Co, Kenilworth, NJ, USA. · University of California, San Francisco, San Francisco, CA, USA. · Pubmed 26115796
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Aix-Marseille University, Hôpital de La Timone APHM, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Oncology Specialists SC, Park Ridge, IL, USA. · Assistance Publique Hôpitaux de Paris, Dermatology and CIC Departments, Hôpital Saint Louis, University Paris 7, INSERM U976, France. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, Alberta, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 25840693
  • Gustave Roussy Cancer Campus Grand Paris, 114 rue Edouard Vaillant, 94805 Villejuif, France; INSERM U1015, 94805 Villejuif, France. · Gustave Roussy Cancer Campus Grand Paris, 114 rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 26613660
  • Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. · Institut National de la Recherche Agronomique (INRA), Micalis-UMR1319, 78360 Jouy-en-Josas, France. · University of Lille, CNRS, INSERM, Centre Hospitalier Régional Universitaire de Lille, Institut Pasteur de Lille, U1019, UMR 8204, Centre d'Infection et d'Immunité de Lille (CIIL), F-59000 Lille, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Department of Radiation Oncology, New York University, New York, NY, USA. · Microenvironment and Immunity Unit, Institut Pasteur, Paris, France. · Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. · Department of Genetics and Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. · Animalerie Centrale, Institut Pasteur, Paris, France. · Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale (IPBS), Toulouse, France. Université de Toulouse, Université Paul Sabatier, IPBS, F-31077 Toulouse, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Service de microbiologie, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Laboratory of Immunomonitoring in Oncology, UMS 3655 CNRS/US 23 INSERM, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. INSERM U981, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. INSERM U848, Villejuif, France. Equipe 11 Labellisée-Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, INSERM U1138, Paris, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France. · Unité des Rickettsies, Faculté de Médecine, Université de la Méditerranée, Marseille, France. · Institut Pasteur, Unit of Biology and Genetics of the Bacterial Cell Wall, Paris, France. INSERM, Equipe Avenir, Paris, France. · University of Paris Sud XI, Kremlin-Bicêtre, France. Gastroenterology Department, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Paris, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Pubmed 26541610
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology Department of Surgery, Erasmus MC Cancer Center, Rotterdam, The Netherlands. · Laboratory of Experimental Surgical Oncology, Department of Surgical Oncology, Erasmus MC Cancer Institute, PO Box 2040, 3000, CA, Rotterdam, The Netherlands. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology Department of Surgery, Erasmus MC Cancer Center, Rotterdam, The Netherlands. · Department of Pharmaceutics, Mashhad University of Medical Sciences, Mashhad, Iran. · Institut Gustave Roussy, Villejuif, France. · Pubmed 26202516
  • 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] INSERM, Unité Mixte de Recherche_S959, I, Paris, France [2] Assistance-Publique Hopitaux de Paris, Hôpital Pitié-Salpêtrière, Biotherapy, Paris, France. · INSERM U753, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] Department of Medical Oncology, IGR, Villejuif, France. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Ludwig Center for Cancer Immunotherapy, Department of Immunology, and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland [2] Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland. · Department of Dermatology, University Hospital Essen, Germany. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Bristol-Myers Squibb, Redwood City, CA, USA. · Earle A Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · 1] QIMR Berghofer Medical Research Institute, Herston, 4006, Queensland, Australia [2] School of Medicine, The University of Queensland, Herston, QLD 4006, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Department of Medical Oncology, IGR, Villejuif, France [4] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France [4] Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, INSERM U 1138, Paris, France [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France [6] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France [4] Department of Medical Oncology, IGR, Villejuif, France. · Pubmed 25582080
  • Dept. of Dermatology, Harzklinikum Quedlinburg, Germany. · Department of Surgical Oncology, Erasmus University Medical Center - Daniel den Hoed Cancer Center, Rotterdam, Netherlands. · Surgery, Institut de Cancérologie, Gustav Roussy, Villejuif, France. · Department of Dermatology, Charité, Humboldt University, Berlin, Germany. · Pubmed 24764213
2014
  • Melanoma Unit and INSERM U981, Gustave Roussy Cancer Institute, Grand Paris, Villejuif, France; Erasmus University Medical Centre, Rotterdam, Netherlands. Electronic address: · Department of Pathology, McGill University & Lady Davis Institute for Medical Research, Montreal, QC, Canada. · Melanoma Unit and INSERM U981, Gustave Roussy Cancer Institute, Grand Paris, Villejuif, France. · Pubmed 24054424
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Cancer Institute, Gustave Roussy Cancer Campus, Grand Paris, 114 rue Édouard Vaillant, 94805 Villejuif, France. · Pubmed 25311352
  • 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France [4]. · 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3]. · 1] Inserm UMR981, Villejuif F-94805, France [2]. · Inserm UMR981, Villejuif F-94805, France. · 1] Inserm UMR981, Villejuif F-94805, France [2] Department of Surgical and Perioperative Sciences, Umeå University, Umeå SE-90187, Sweden (O.H.); CNRS UMR3348, Institut Curie, Orsay F-91405, France (S.V.). · Gustave Roussy, Pathology Department, Villejuif F-94805, France. · Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France. · CNRS-Strasbourg University, UMR7200, Illkirch F-67400, France. · 1] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [2] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France. · 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France. · 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France [4] Department of Surgical and Perioperative Sciences, Umeå University, Umeå SE-90187, Sweden (O.H.); CNRS UMR3348, Institut Curie, Orsay F-91405, France (S.V.). · Pubmed 25079330
  • Department of Dermatology, Charité, Humboldt University of Berlin, Berlin, Germany; European Organization for Research and Treatment of Cancer (EORTC) Melanoma Group (MG), Brussels, Belgium. Electronic address: · Department of Surgical Oncology, Erasmus University Medical Center - Daniel den Hoed Cancer Center, Rotterdam, The Netherlands; European Organization for Research and Treatment of Cancer (EORTC) Melanoma Group (MG), Brussels, Belgium. · Department of Dermatology, Charité, Humboldt University of Berlin, Berlin, Germany. · Department of Hematology and Oncology, Armed Forces Hospital, Ulm, Germany. · Institut de Cancérologie Gustav Roussy, Paris-Sud/Villejuif, France; European Organization for Research and Treatment of Cancer (EORTC) Melanoma Group (MG), Brussels, Belgium. · Pubmed 24999208
  • Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Cancer Institute, Gustave Roussy Cancer Campus, Grand Paris, 114 rue Édouard Vaillant, 94805 Villejuif, France. · Pubmed 24710577
  • 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA. [2]. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA. · Department of Dermatology, Maurizio Bufalini Hospital, Cesena, Italy. · Department of Dermatology, University of L'Aquila, L'Aquila, Italy. · 1] Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. [2] Genetics of Rare Hereditary Cancers, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Service de Génétique, Gustave Roussy, Villejuif, France. · 1] Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain. [2] Department of Dermatology, Universidad Católica de Valencia, Valencia, Spain. · Université Paris Descartes, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France. · 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA. [2] Cancer Genomics Research Laboratory, NCI-Frederick, SAIC-Frederick, Inc., Frederick, Maryland, USA. · Genetics of Rare Hereditary Cancers, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Dermatology, Hospital General Universitario de Alicante, Alicante, Spain. · Laboratory of Molecular Biology, Instituto Valenciano de Oncología, Valencia, Spain. · 1] INSERM, UMR 946, Genetic Variation and Human Diseases Unit, Paris, France. [2] Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France. · 1] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. · SAS Quantome, Paris, France. · Laboratory of Molecular Gerontology, National Institute on Aging, US National Institutes of Health, US Department of Health and Human Services, Baltimore, Maryland, USA. · Section of Medical Sciences, School of Molecular Biosciences, Washington State University, Spokane, Washington, USA. · Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. · SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Simulation, Analysis and Mathematical Modeling Group, Advanced Biomedical Computing Center, Frederick, Maryland, USA. · 1] Service de Génétique, Gustave Roussy, Villejuif, France. [2] Université Paris-Sud, Kremlin Bicêtre France, Gustave Roussy, Villejuif, France. · 1] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [3] Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain (CEPH), Paris, France. · Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. · Pubmed 24686846
  • 1] Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands [2]. · 1] Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands [2] Department of Biochemistry, The Rosalind and Morris Goodman Cancer Centre, McGill University, Montreal, Quebec H3G 1Y6, Canada [3]. · Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Division of Medical Oncology, Cancer Systems Biology Centre and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Division of Pathology, Cancer Systems Biology Centre and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · 1] Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands [2] Department of Pathology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · 1] University of Torino, Department of Oncology, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy [2] Candiolo Cancer Institute - FPO, IRCCS, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy. · Candiolo Cancer Institute - FPO, IRCCS, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy. · 1] University of Torino, Department of Oncology, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy [2] Candiolo Cancer Institute - FPO, IRCCS, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy [3] FIRC Institute of Molecular Oncology (IFOM), 20139 Milano, Italy. · Pubmed 24670642
  • The University of Queensland, UQ Centre for Clinical Research, Experimental Dermatology Group, Brisbane, QLD, Australia; The University of Queensland, UQ Diamantina Institute, Translational Research Institute, Woolloongabba, QLD, Australia. Electronic address: · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · QIMR Berghofer Medical Research Institute, Cancer and Population Studies Group, Brisbane, Australia. · The University of Queensland, UQ Centre for Clinical Research, Experimental Dermatology Group, Brisbane, QLD, Australia. · Queensland Melanoma Project, Discipline of Surgery, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, QLD, Australia. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Institut de Cancérologie Gustave Roussy, Villejuif-Paris, France. · QIMR Berghofer Medical Research Institute, Cancer and Population Studies Group, Brisbane, Australia; Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK. · Pubmed 24613127
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands; Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands; Institut de Cancérologie Gustave Roussy, 94800 Paris, France. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands. Electronic address: · Pubmed 24269966
  • Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Institut de Cancerologie Gustav Roussy, Villejuif, Paris-Sud, France. Electronic address: · Pubmed 24074765
  • Cancer Institute, Gustave Roussy Cancer Campus, Grand Paris, 114 rue Édouard Vaillant, 94805 Villejuif, France. · Department of Dermatology, Gustave Roussy Cancer Campus, Grand Paris, 114 rue Édouard Vaillant, 94805 Villejuif, France. · Pubmed 24590131
2013
2012
  • Cancer Institute Gustave-Roussy, Villejuif/Paris-Sud 94800, France. · Pubmed 22918930
  • Institut de Cancérologie Gustave Roussy, Villejuif, Paris, France. · Pubmed 22234255
  • Institut de Cancérologie Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, Paris-Sud, France. · Pubmed 22231762
  • Institute de Cancérologie Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, Paris-Sud, France. · Pubmed 23008300
  • Institut de Cancérologie Gustave Roussy, Villejuif, France. · Pubmed 22056637
2011
  • Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, France. · Pubmed 21802280
2010
2018
  • European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; The Christie NHS Foundation Trust, Manchester, UK; University of Pittsburgh Cancer Institute and School of Medicine, Pittsburgh, PA; Mayo Clinic Rochester, Rochester, MN; University of Tubingen, Tubingen, Germany; University of Edinburgh, Western General Hospital, Edinburgh, UK; Bristol-Myers Squibb, Wallingford, CT; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK; Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK; Universitas Brawijaya, Malang, Indonesia; IDDI, Louvain-la-Neuve, Belgium. · Pubmed 28922786
  • From the Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay, Villejuif (A.M.M.E., C.R.), Hospices Civils de Lyon Cancer Institute, Cancer Research Center of Lyon, Lyon University, Lyon (S.D.), and Aix-Marseille University, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille (J.-J.G.) - all in France; Netherlands Cancer Institute-Antoni van Leeuwenhoek (C.U.B., A.C.J.A.) and VU University Medical Center (A.J.M.E.), Amsterdam, and Radboud University Medical Center Nijmegen, Nijmegen (R.K.) - all in the Netherlands; Azienda Ospedaliera Papa Giovanni XXIII, Bergamo (M. Mandala), Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples (P.A.A.), and Universita Degli Studi Di Siena-Policlinico le Scotte, Siena (M. Maio) - all in Italy; Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals (G.V.L.) and Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney (M.S.C.), Sydney, Princess Alexandra Hospital, University of Queensland, Brisbane (V.A.), Alfred Hospital (A.H.) and Peter MacCallum Cancer Centre (S. Sandhu), Melbourne, VIC, and Fiona Stanley Hospital-University of Western Australia-Edith Cowan University Perth, Perth (A.K.) - all in Australia; Cancer Research Center, Moscow (M.L.); Royal Marsden Hospital, London (J.L.); Hospital Clinic Universitari de Barcelona, Barcelona (S.P.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); University Hospital Essen, Essen and German Cancer Consortium, Heidelberg (D.S.), and the Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover (R.G.) - all in Germany; Washington University School of Medicine, St. Louis (L.H.-A.); Centre Hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du CHUM, Montreal (R.J.); Christie NHS Foundation Trust, Manchester, United Kingdom (P.L.); Merck, Kenilworth, NJ (N.I.); and the European Organization for the Research and Treatment of Cancer Headquarters, Brussels (S.M., S. Suciu). · Pubmed 29658430
2016
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France; the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy; University of Zurich Hospital, Zurich, Switzerland (R.D.); Memorial Sloan Kettering Cancer Center, New York (J.D.W.); Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark; the Angeles Clinic and Research Institute, Los Angeles (O.H.); Oncology Specialists, Park Ridge, IL (J.M.R.); Cross Cancer Institute, Edmonton, AB, Canada (M.S.); H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.); Broomfield Hospital, Chelmsford, United Kingdom (S.T.); Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany; Dana-Farber Cancer Institute, Boston (F.S.H.); Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.); and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
  • aDepartment of Oncology, Odense University Hospital, Odense C bThe Finsen Laboratory, Rigshospitalet, and Biotech Research and Innovation Centre, University of Copenhagen, København Departments of cOncology dMedicine ePathology, Herlev University Hospital, Herlev fAarhus University Hospital, Aarhus, Denmark gDepartment of Surgical Oncology, Erasmus University Medical Center-Daniel Den Hoed Cancer Center, Rotterdam, The Netherlands hKarolinska Institute, Stockholm, Sweden iEORTC Headquarters, Brussels, Belgium jGustave Roussy Cancer Institute, Villejuif, France. · Pubmed 27076041
  • aDepartment of Dermatology, Venerology and Allergology, Charité - University of Medicine Berlin, Berlin bDepartment of Dermatology, Harz Skin Cancer Center, Quedlinburg, Germany cDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam dDepartment of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands eGustav Roussy, Institute of Oncology, Villejuif/Paris-Sud, France. · Pubmed 26881876
2015
  • 1Service of Oncology, Hospital La Paz, Madrid, Spain; 2Department of Dermatology, Hopital Ste Marguerite, Marseille, France; 3Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 4Department of Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; 5Department of Dermatology (CR), and General Director (AE), Institute Gustave Roussy, Villejuif Cedex, France; 6First Department of Medicine, University of Athens Medical School, Athens, Greece; 7Department of Oncology, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia; 8Service of Oncology, Clinica Universitaria de Navarra, Pamplona, Spain; 9Department of Dermatology, University of Kiel, Kiel, Germany; and 10Department of Dermatology, University Hospital Essen, Essen, Germany. · Pubmed 24413374
  • 1Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori-Fondazione G. Pascale, Naples, Italy; 2Odense University Hospital, Odense, Denmark; 3Newcastle University, Newcastle, Australia; 4Instituto de Oncologia Angel Rolfo, Buenos Aires, Argentina; 5Institut Gustave Roussy, Villejuif, France; 6University of Kiel, Kiel, Germany; 7Hospital La Paz, Madrid, Spain; and 8Institut Gustave Roussy, Villejuif, France. · Pubmed 24185314
  • 1First Department of Medicine, Athens University Medical School, Athens, Greece; 2Division of Medical Oncology, Baskent University School of Medicine, Adana, Turkey; 3Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy; 4Department of Biotherapy, Blokhin Cancer Center, Moscow, Russia; 5Department of Dermatology, Medical University of Vienna, Vienna, Austria; 6Department of Dermatology, Institute Gustave Roussy, Villejuif Cedex, France; 7Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel; 8Department of Dermatologie, University of Kiel, Kiel, Germany; and 9Oncology Service, Hospital La Paz, Madrid, Spain. · Pubmed 24176884
  • aDepartment of Surgical Oncology, Erasmus MC-Cancer Institute, Rotterdam, The Netherlands bGustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Pubmed 26110555
2014
  • Authors' Affiliations: Cancer Institute Gustave Roussy; Departments of Epidemiology and Statistics and Dermatology; Stabilité génétique et oncogenèse UMR 8200; Clinical Oncology, Melanoma Branch, Cancer Institute Gustave Roussy; Department of BioPathology, Translational Research Laboratory and Biobank, Institute Gustave Roussy; Institut National de la Santé et de la Recherche Medicale (INSERM), U1015; Center of Clinical Investigations CBT507, Biotherapy, Villejuif; INSERM U1102, Institut de Cancérologie de l'Ouest, Saint Herblain; INSERM, U892, Institut de Recherche Thérapeutique, Nantes; INSERM, U1016, Saint Vincent de Paul Hospital; INSERM U1016, CNRS UMR8104, Cochin Institute; Faculté Paris Sud-Université Paris XI, Paris, France; and IRCCS San Matteo University Hospital Foundation, Pavia, Italy. · Pubmed 24197135
  • aDepartment of Dermatology, Charité, Humboldt University of Berlin, Berlin bDepartment of Dermatology, University of Mainz, Mainz, Germany cDepartment of Surgical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands dInstitute Gustave Roussy Cancer Center, Villejuif, Paris Sud, France. · Pubmed 25003535
2013
  • Alexander M.M. Eggermont, Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, and Université Paris-Sud, Kremlin Bicêtre, Paris, France; Stefan Suciu, Larissa Polders, and Michel Praet, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Jeremy Marsden, University Hospital Birmingham, Birmingham; Philippa Corrie, Addenbrookes Hospital, Cambridge; Poulam M. Patel, University of Nottingham, Nottingham; Neville Davidson, Broomfield Hospital, Broomfield, United Kingdom; Mario Santinami, Istituto Nazionale dei Tumori, Milan; Paolo A. Ascierto, Istituto Nazionale Tumori Fondazione Pascale, Napoli; Lorenzo Borgognoni, Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence; Maria Grazia Bernengo, University Hospital Turin, Turin, Italy; Steinar Aamdal, Oslo University Hospital and Radium Hospital, Oslo, Norway; Wim H. Kruit, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands; Lars Bastholt, Odense University Hospital, Odense, Denmark; and Alan Spatz, McGill University and Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Pubmed 24019551
  • Gustave Roussy Comprehensive Cancer Center, 114 Rue Edouard Vaillant, 94800 Villejuif/Paris-Sud, France. · Pubmed 23907003
  • Dermatology Unit, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Pubmed 23439861
2012
  • Department of Surgery, Institut Gustave-Roussy, Villejuif Cedex, France. · Pubmed 22241290
Miscellaneous cities in France
2018
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France · · European Organization for the Research and Treatment of Cancer Headquarters, Brussels, Belgium · Pubmed 30089063
2011
  • Department of Epidemiology and Biostatistics, International Prevention Research Institute, France. · Pubmed 21192263
Universite Paris 11 Sud
2017
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; Universite Paris-Sud, Kremlin-Bicêtre, France. Electronic address: · University Hospital Zürich, Department of Dermatology, Zürich, Switzerland. · Pubmed 28968566
2016
  • Dermatology Service, Department of Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · University of Pittsburgh, 4200 Fifth Avenue, Pittsburgh, Pennsylvania 15260, USA. · AP-HP, Internal Medicine Department, University Hospital of Bicêtre, 78 Rue du General Leclerc, 94270 Le Kremlin-Bicetre, France. · Paris Sud University, 63 Rue Gabriel Peri, 94270 Le Kremlin Bicêtre, France. · INSERM Unit U1184, 63 Rue Gabriel Peri, 94270 Le Kremlin Bicêtre, France. · Thoracic and Vascular Surgery Service, Centre Chirurgical Marie Lannelongue, 133 Avenue de la Resistance, 92350 Le Plessis-Robinson, France. · AP-HP, Department of Gastroenterology, University Hospital of Bicêtre, Paris Sud University, 78 Rue du General Leclerc, 94270 Le Kremlin-Bicetre, France. · Department of Nephrology, Pitié-Salpêtrière Hospital, 47-83 Boulevard de l'hopital, 75013 Paris, France. · Drug Development Department (DITEP), Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · INSERM Unit U981, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · Biostatistic and Epidemiology Unit, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 27141885
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; Universite Paris-Sud, Kremlin-Bicêtre, France. Electronic address: · Pubmed 27816830
2015
  • Gustave Roussy Cancer Campus Grand Paris and University Paris-Sud, Paris, France. Electronic address: · Medical Oncology and Immunotherapy, University Hospital Siena, Italy. · Gustave Roussy Cancer Campus Grand Paris and University Paris-Sud, Paris, France. · Pubmed 25965361
  • University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · University Hospital Essen, Essen, Germany. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sheba Medical Center, Tel Hashomer, Israel. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. · University Medical Center, Mainz, Germany. · Universitätsklinikum Tübingen, Tübingen, Germany. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. · St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. · University of North Carolina, Chapel Hill, NC, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Merck & Co, Kenilworth, NJ, USA. · University of California, San Francisco, San Francisco, CA, USA. · Pubmed 26115796
2014
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France [4]. · 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3]. · 1] Inserm UMR981, Villejuif F-94805, France [2]. · Inserm UMR981, Villejuif F-94805, France. · 1] Inserm UMR981, Villejuif F-94805, France [2] Department of Surgical and Perioperative Sciences, Umeå University, Umeå SE-90187, Sweden (O.H.); CNRS UMR3348, Institut Curie, Orsay F-91405, France (S.V.). · Gustave Roussy, Pathology Department, Villejuif F-94805, France. · Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France. · CNRS-Strasbourg University, UMR7200, Illkirch F-67400, France. · 1] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [2] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France. · 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France. · 1] Inserm UMR981, Villejuif F-94805, France [2] Université Paris-Sud XI, Kremlin-Bicêtre F-94276, France [3] Gustave Roussy, Dermato-Oncology, Villejuif F-94805, France [4] Department of Surgical and Perioperative Sciences, Umeå University, Umeå SE-90187, Sweden (O.H.); CNRS UMR3348, Institut Curie, Orsay F-91405, France (S.V.). · Pubmed 25079330
  • 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA. [2]. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA. · Department of Dermatology, Maurizio Bufalini Hospital, Cesena, Italy. · Department of Dermatology, University of L'Aquila, L'Aquila, Italy. · 1] Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. [2] Genetics of Rare Hereditary Cancers, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Service de Génétique, Gustave Roussy, Villejuif, France. · 1] Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain. [2] Department of Dermatology, Universidad Católica de Valencia, Valencia, Spain. · Université Paris Descartes, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France. · 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA. [2] Cancer Genomics Research Laboratory, NCI-Frederick, SAIC-Frederick, Inc., Frederick, Maryland, USA. · Genetics of Rare Hereditary Cancers, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Dermatology, Hospital General Universitario de Alicante, Alicante, Spain. · Laboratory of Molecular Biology, Instituto Valenciano de Oncología, Valencia, Spain. · 1] INSERM, UMR 946, Genetic Variation and Human Diseases Unit, Paris, France. [2] Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France. · 1] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. · SAS Quantome, Paris, France. · Laboratory of Molecular Gerontology, National Institute on Aging, US National Institutes of Health, US Department of Health and Human Services, Baltimore, Maryland, USA. · Section of Medical Sciences, School of Molecular Biosciences, Washington State University, Spokane, Washington, USA. · Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. · SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Simulation, Analysis and Mathematical Modeling Group, Advanced Biomedical Computing Center, Frederick, Maryland, USA. · 1] Service de Génétique, Gustave Roussy, Villejuif, France. [2] Université Paris-Sud, Kremlin Bicêtre France, Gustave Roussy, Villejuif, France. · 1] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [3] Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain (CEPH), Paris, France. · Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. · Pubmed 24686846
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
2016
  • aDepartment of Dermatology, Venerology and Allergology, Charité - University of Medicine Berlin, Berlin bDepartment of Dermatology, Harz Skin Cancer Center, Quedlinburg, Germany cDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam dDepartment of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands eGustav Roussy, Institute of Oncology, Villejuif/Paris-Sud, France. · Pubmed 26881876
2014
  • Authors' Affiliations: Cancer Institute Gustave Roussy; Departments of Epidemiology and Statistics and Dermatology; Stabilité génétique et oncogenèse UMR 8200; Clinical Oncology, Melanoma Branch, Cancer Institute Gustave Roussy; Department of BioPathology, Translational Research Laboratory and Biobank, Institute Gustave Roussy; Institut National de la Santé et de la Recherche Medicale (INSERM), U1015; Center of Clinical Investigations CBT507, Biotherapy, Villejuif; INSERM U1102, Institut de Cancérologie de l'Ouest, Saint Herblain; INSERM, U892, Institut de Recherche Thérapeutique, Nantes; INSERM, U1016, Saint Vincent de Paul Hospital; INSERM U1016, CNRS UMR8104, Cochin Institute; Faculté Paris Sud-Université Paris XI, Paris, France; and IRCCS San Matteo University Hospital Foundation, Pavia, Italy. · Pubmed 24197135
  • aDepartment of Dermatology, Charité, Humboldt University of Berlin, Berlin bDepartment of Dermatology, University of Mainz, Mainz, Germany cDepartment of Surgical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands dInstitute Gustave Roussy Cancer Center, Villejuif, Paris Sud, France. · Pubmed 25003535
2013
  • Alexander M.M. Eggermont, Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, and Université Paris-Sud, Kremlin Bicêtre, Paris, France; Stefan Suciu, Larissa Polders, and Michel Praet, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Jeremy Marsden, University Hospital Birmingham, Birmingham; Philippa Corrie, Addenbrookes Hospital, Cambridge; Poulam M. Patel, University of Nottingham, Nottingham; Neville Davidson, Broomfield Hospital, Broomfield, United Kingdom; Mario Santinami, Istituto Nazionale dei Tumori, Milan; Paolo A. Ascierto, Istituto Nazionale Tumori Fondazione Pascale, Napoli; Lorenzo Borgognoni, Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence; Maria Grazia Bernengo, University Hospital Turin, Turin, Italy; Steinar Aamdal, Oslo University Hospital and Radium Hospital, Oslo, Norway; Wim H. Kruit, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands; Lars Bastholt, Odense University Hospital, Odense, Denmark; and Alan Spatz, McGill University and Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Pubmed 24019551
Erasmus University Rotterdam
2016
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. Electronic address: · Department of Dermatology, Venerology and Allergology, Charité - University, Medicine Berlin, Berlin, Germany. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. Electronic address: · Department of Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; General Director, Department of Surgical Oncology, Gustave Roussy Cancer Campus Grand Paris, Villejuif/Paris-Sud, France. Electronic address: · Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: · Pubmed 27669503
  • Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: · Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · Pubmed 27522248
  • Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands; Erasmus Optical Imaging Center, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: · Pubmed 26707830
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, POBox 1738, 3000, DR, Rotterdam, The Netherlands. · Institut Gustave Roussy, Villejuif, France. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, POBox 1738, 3000, DR, Rotterdam, The Netherlands. · Pubmed 26518763
2015
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology Department of Surgery, Erasmus MC Cancer Center, Rotterdam, The Netherlands. · Laboratory of Experimental Surgical Oncology, Department of Surgical Oncology, Erasmus MC Cancer Institute, PO Box 2040, 3000, CA, Rotterdam, The Netherlands. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology Department of Surgery, Erasmus MC Cancer Center, Rotterdam, The Netherlands. · Department of Pharmaceutics, Mashhad University of Medical Sciences, Mashhad, Iran. · Institut Gustave Roussy, Villejuif, France. · Pubmed 26202516
2014
  • Melanoma Unit and INSERM U981, Gustave Roussy Cancer Institute, Grand Paris, Villejuif, France; Erasmus University Medical Centre, Rotterdam, Netherlands. Electronic address: · Department of Pathology, McGill University & Lady Davis Institute for Medical Research, Montreal, QC, Canada. · Melanoma Unit and INSERM U981, Gustave Roussy Cancer Institute, Grand Paris, Villejuif, France. · Pubmed 24054424
  • The University of Queensland, UQ Centre for Clinical Research, Experimental Dermatology Group, Brisbane, QLD, Australia; The University of Queensland, UQ Diamantina Institute, Translational Research Institute, Woolloongabba, QLD, Australia. Electronic address: · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · QIMR Berghofer Medical Research Institute, Cancer and Population Studies Group, Brisbane, Australia. · The University of Queensland, UQ Centre for Clinical Research, Experimental Dermatology Group, Brisbane, QLD, Australia. · Queensland Melanoma Project, Discipline of Surgery, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, QLD, Australia. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Institut de Cancérologie Gustave Roussy, Villejuif-Paris, France. · QIMR Berghofer Medical Research Institute, Cancer and Population Studies Group, Brisbane, Australia; Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK. · Pubmed 24613127
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands; Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands; Institut de Cancérologie Gustave Roussy, 94800 Paris, France. · Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands. Electronic address: · Pubmed 24269966
2010
  • Department of Surgical Oncology, Erasmus University Medical Center - Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Pubmed 20943639
  • Department of Surgical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, 310 Groene Hilledijk, 3075 EA, Rotterdam, The Netherlands. · Pubmed 19621225
2009
  • Department of Surgical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Pubmed 19617295
  • Department of Surgical Oncology, Erasmus University MC, Daniel den Hoed Cancer Center, 301 Groene Hilledijk, 3075 EA Rotterdam, The Netherlands. · Pubmed 19477117
  • Department of Surgical Oncology, Erasmus University MC-Daniel den Hoed Cancer Center, 301 Groene Hilledijk, 3075 EA Rotterdam, The Netherlands. · Pubmed 19464602
  • Department of Surgical Oncology, Daniel den Hoed Cancer Center, Erasmus University MC, Rotterdam, The Netherlands. · Pubmed 19390551
2008
  • Department of Surgical Oncology, Erasmus University Medical Center - Daniel den Hoed Cancer Center, 301 Groene Hilledijk, 3075 EA Rotterdam, The Netherlands. · Pubmed 18486887
  • Erasmus University Medical Center, Rotterdam, Netherlands. · Pubmed 18620949
2016
  • aDepartment of Oncology, Odense University Hospital, Odense C bThe Finsen Laboratory, Rigshospitalet, and Biotech Research and Innovation Centre, University of Copenhagen, København Departments of cOncology dMedicine ePathology, Herlev University Hospital, Herlev fAarhus University Hospital, Aarhus, Denmark gDepartment of Surgical Oncology, Erasmus University Medical Center-Daniel Den Hoed Cancer Center, Rotterdam, The Netherlands hKarolinska Institute, Stockholm, Sweden iEORTC Headquarters, Brussels, Belgium jGustave Roussy Cancer Institute, Villejuif, France. · Pubmed 27076041
  • aDepartment of Dermatology, Venerology and Allergology, Charité - University of Medicine Berlin, Berlin bDepartment of Dermatology, Harz Skin Cancer Center, Quedlinburg, Germany cDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam dDepartment of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands eGustav Roussy, Institute of Oncology, Villejuif/Paris-Sud, France. · Pubmed 26881876
2015
  • aDepartment of Surgical Oncology, Erasmus MC-Cancer Institute, Rotterdam, The Netherlands bGustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Pubmed 26110555
  • Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands, · Pubmed 25408275
2014
  • aDepartment of Dermatology, Charité, Humboldt University of Berlin, Berlin bDepartment of Dermatology, University of Mainz, Mainz, Germany cDepartment of Surgical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands dInstitute Gustave Roussy Cancer Center, Villejuif, Paris Sud, France. · Pubmed 25003535
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, Room Ee 0104a, PO Box 1738, 3000 DR, Rotterdam, The Netherlands. · Pubmed 24221409
2013
  • Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, the Netherlands. · Pubmed 23328628
  • Alexander M.M. Eggermont, Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, and Université Paris-Sud, Kremlin Bicêtre, Paris, France; Stefan Suciu, Larissa Polders, and Michel Praet, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Jeremy Marsden, University Hospital Birmingham, Birmingham; Philippa Corrie, Addenbrookes Hospital, Cambridge; Poulam M. Patel, University of Nottingham, Nottingham; Neville Davidson, Broomfield Hospital, Broomfield, United Kingdom; Mario Santinami, Istituto Nazionale dei Tumori, Milan; Paolo A. Ascierto, Istituto Nazionale Tumori Fondazione Pascale, Napoli; Lorenzo Borgognoni, Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence; Maria Grazia Bernengo, University Hospital Turin, Turin, Italy; Steinar Aamdal, Oslo University Hospital and Radium Hospital, Oslo, Norway; Wim H. Kruit, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands; Lars Bastholt, Odense University Hospital, Odense, Denmark; and Alan Spatz, McGill University and Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Pubmed 24019551
  • Department of Internal Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands. · Pubmed 23715572
  • Erasmus University Medical Center, Rotterdam, The Netherlands. · Pubmed 23690423
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands. · Pubmed 23524188
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, 3000CA Rotterdam, The Netherlands. · Pubmed 23391444
2012
  • Erasmus University Medical Centre-Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands. · Pubmed 22961519
  • Department of Public Health, Erasmus University Medical Center, PO Box 2040 3000 CA, Rotterdam, the Netherlands. · Pubmed 22547594
  • Department of Surgical Oncology, ErasmusMC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Pubmed 21879272
2011
  • Department of Surgery, Division Surgical Oncology, Erasmus University Medical Center - Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Pubmed 21367679
  • Department of Surgery, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Pubmed 21150603
  • Department of Surgical Oncology, Daniel den Hoed Cancer Centre, Erasmus MC, Rotterdam, The Netherlands. · Pubmed 21150602
  • Department of Surgical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Pubmed 21537867
  • Department of Surgical Oncology, Erasmus University MC - Daniel den Hoed Cancer Center, 301 Groene Hilledijk, 3075 EA Rotterdam, The Netherlands. · Pubmed 21087856
  • Division of Surgical Oncology, Erasmus MC- Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands. · Pubmed 21739427
  • Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Pubmed 21611857
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus MC, Rotterdam 3015 GE, The Netherlands. · Pubmed 21546857
  • Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Pubmed 21519012
  • Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands. · Pubmed 21150923
2010
  • Department of Surgical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Groene Hilledijk 301, Kamer A1-41, 3075 EA Rotterdam, The Netherlands. · Pubmed 20567244
  • Department of Surgical Oncology, Erasmus University Medical Center - Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Pubmed 20168231
  • Department of Surgery, Division Surgical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands. · Pubmed 20385998
  • Department of Surgical Oncology, Erasmus University Medical Center, The Netherlands. · Pubmed 20621467
  • Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands. · Pubmed 20218981
  • Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands. · Pubmed 20074595
  • Erasmus Medical Center-Daniel den Hoed Cancer Center, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands. · Pubmed 19672595
2009
  • Erasmus University Medical Centre - Daniel den Hoed Cancer Centre, Department of Surgical Oncology, Groene Hilledijk 301 - Kamer A1-41, 3075 EA Rotterdam, The Netherlands. · Pubmed 19767199
  • Department of Surgical Oncology, Erasmus University MC-Daniel den Hoed Cancer Center, 301 Groene Hilledijk, Rotterdam, the Netherlands. · Pubmed 19509353
  • Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands. · Pubmed 18953681
  • Department of Surgical Oncology, Erasmus University Medical Centre-Daniel den Hoed Cancer Centre, P.O. Box 5201, 3008 AE Rotterdam, the Netherlands. · Pubmed 18760560
2008
  • Department of Surgical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, P.O. Box 5201, 301 Groene Hilledijk, 3008 AE, Rotterdam, The Netherlands. · Pubmed 18617395
  • Department of Surgical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Pubmed 19092339
  • Department of Surgical Oncology, Erasmus University MC-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands. · Pubmed 18376421
  • Dept. of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands. · Pubmed 18212177
INSERM Paris
2014
  • Melanoma Unit and INSERM U981, Gustave Roussy Cancer Institute, Grand Paris, Villejuif, France; Erasmus University Medical Centre, Rotterdam, Netherlands. Electronic address: · Department of Pathology, McGill University & Lady Davis Institute for Medical Research, Montreal, QC, Canada. · Melanoma Unit and INSERM U981, Gustave Roussy Cancer Institute, Grand Paris, Villejuif, France. · Pubmed 24054424
2016
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France; the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy; University of Zurich Hospital, Zurich, Switzerland (R.D.); Memorial Sloan Kettering Cancer Center, New York (J.D.W.); Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark; the Angeles Clinic and Research Institute, Los Angeles (O.H.); Oncology Specialists, Park Ridge, IL (J.M.R.); Cross Cancer Institute, Edmonton, AB, Canada (M.S.); H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.); Broomfield Hospital, Chelmsford, United Kingdom (S.T.); Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany; Dana-Farber Cancer Institute, Boston (F.S.H.); Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.); and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
2014
  • Authors' Affiliations: Cancer Institute Gustave Roussy; Departments of Epidemiology and Statistics and Dermatology; Stabilité génétique et oncogenèse UMR 8200; Clinical Oncology, Melanoma Branch, Cancer Institute Gustave Roussy; Department of BioPathology, Translational Research Laboratory and Biobank, Institute Gustave Roussy; Institut National de la Santé et de la Recherche Medicale (INSERM), U1015; Center of Clinical Investigations CBT507, Biotherapy, Villejuif; INSERM U1102, Institut de Cancérologie de l'Ouest, Saint Herblain; INSERM, U892, Institut de Recherche Thérapeutique, Nantes; INSERM, U1016, Saint Vincent de Paul Hospital; INSERM U1016, CNRS UMR8104, Cochin Institute; Faculté Paris Sud-Université Paris XI, Paris, France; and IRCCS San Matteo University Hospital Foundation, Pavia, Italy. · Pubmed 24197135
Unspecified
2014
  • Department of Medical Oncology. · Department of Medical Oncology,, INSERM U981. · Dermatology Clinic, Hôtel Dieu, Nantes, FRANCE. · Department of Radiation Oncology. · Department of Radiology, Institute Gustave Roussy, 114 rue Edouard Vaillant, 94800 Villejuif, FRANCE. · INSERM U981. · Pubmed 24721778
81 Other Locations Show
Yearly article counts 39201321161321182311
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.